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Background: The construction of customized nucleic acid sequences allows us to have greater flexibility in gene
design for recombinant protein expression. Among the various parameters considered for such DNA sequence
design, individual codon usage (ICU) has been implicated as one of the most crucial factors affecting mRNA
translational efficiency. However, previous works have also reported the significant influence of codon pair usage,
also known as codon context (CC), on the level of protein expression.
Results: In this study, we have developed novel computational procedures for evaluating the relative importance
of optimizing ICU and CC for enhancing protein expression. By formulating appropriate mathematical expressions
to quantify the ICU and CC fitness of a coding sequence, optimization procedures based on genetic algorithm were
employed to maximize its ICU and/or CC fitness. Surprisingly, the in silico validation of the resultant optimized DNA
sequences for Escherichia coli, Lactococcus lactis, Pichia pastoris and Saccharomyces cerevisiae suggests that CC is a
more relevant design criterion than the commonly considered ICU.
Conclusions: The proposed CC optimization framework can complement and enhance the capabilities of current
gene design tools, with potential applications to heterologous protein production and even vaccine development
in synthetic biotechnology.Background
Recent developments in artificial gene synthesis have
enabled the construction of synthetic gene circuits [1]
and even the synthesis of whole bacterial genome [2].
The introduction of synthetic genes into a living system
can either modulate existing biological functions or give
rise to novel cellular behavior. In this sense, de novo
gene synthesis is a valuable synthetic biological tool for
biotechnological studies, which typically aims to improve
tolerance to toxic molecules, retrofit existing biosyn-
thetic pathways, design novel biosynthetic pathways
and/or enhance heterologous protein production [3,4].
In the aspect of recombinant protein production, natural
genes found in wild-type organisms are usually trans-
formed into the heterologous hosts for recombinant ex-
pression. This approach typically results in poorly* Correspondence: cheld@nus.edu.sg
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reproduction in any medium, provided the orexpressed recombinant protein since the wild-type for-
eign genes have not been evolved for optimum expres-
sion in the host. Thus, it is highly desirable to harness
the flexibility in synthetic biology to create customized
artificial gene designs that are optimal for heterologous
protein expression. To aid the gene design process, com-
putational tools have been developed for designing cod-
ing sequences based on some performance criteria.
Specifically, the degeneracy of the genetic code,
reflected by the use of sixty-four codons to encode
twenty amino acids and translation termination signal,
leads to the situation whereby all amino acids, except
methionine and tryptophan, can be encoded by two to
six synonymous codons. Notably, the synonymous
codons are not equally utilized to encode the amino
acids, thus resulting in phenomenon of codon usage bias
which was first reported in a study that examines the fre-
quencies of 61 amino acid codons (i.e. termination
codons are excluded) in 90 genes [5]. The emergence of
codon usage bias in organisms has been largely attributed
to natural selection, mutation, and genetic drift [6]. More
importantly, codon usage bias has been shown to be cor-
related to gene expression level [7,8]. As a result, this biasral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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enhancing recombinant protein production in heterol-
ogous expression hosts [9]. Consequently, the algorithms
implemented in many of the sequence design software
tools, such as Codon optimizer [10], Gene Designer [11],
and OPTIMIZER [12], are mainly focused on the fre-
quency of individual codon occurrences. Notably, the
popular web-based software, known as the Java Codon
Adaptation Tool (JCat), is integrated with the PRODORIC
database to allow convenient retrieval of prokaryotic gen-
etic information [13,14]. However, apart from individual
codon usage (ICU) bias, nonrandom utilization of adjacent
codon pairs in organisms has also been reported in several
studies [15,16]. This phenomenon is termed “codon con-
text” as it implicates some “rule” for organizing neighbor-
ing codons as a result of potential tRNA-tRNA steric
interaction within the ribosomes [17,18]. Codon context
(CC) was shown to correlate with translation elongation
rate such that the usage of rare codon pairs decreased pro-
tein translation rates [19]. Therefore, the incorporation of
CC has been proposed in the conventional ICU-based
gene optimization algorithm GeneOptimizer [20]. Further-
more, a patented technology, known as “Translation
Engineering”, demonstrated that better enhancement in
translational efficiency is achievable by optimizing codon
pair usage in addition to ICU optimization [21]. However,
there is yet a study to investigate the relative effects of
ICU and CC on protein expression. To address this issue,
we propose a computational analysis to evaluate the per-
formance of sequences generated by various ICU and CC
optimization approaches.
In this study, we applied novel computational proce-
dures to generate DNA sequences exhibiting optimal
ICU and CC in Escherichia coli, Lactococcus lactis, Pichia
pastoris and Saccharomyces cerevisiae based on informa-
tion obtained from omics data analysis. While E. coli and
S. cerevisiae has been model organisms for recombinant
protein production studies, we also consider codon
optimization in the Gram-positive bacterium L. lactis
and methylotrophic yeast P. pastoris since they are also
promising candidates for expressing recombinant pro-
teins [22,23]. Assuming that the native DNA sequences
of highly expressed genes have evolved to exhibit optimal
ICU and CC for high in vivo expression, we demon-
strated the efficacy of our computational approaches by
performing a leave-one-out cross-validation on the high-
expression genes for each expression host.Results
Codon optimization formulation
To investigate the relative importance of ICU and CC to-
wards designing sequences for high protein expression,
we implemented three computational procedures: theindividual codon usage optimization (ICO) method gen-
erates a sequence with optimal ICU only; the codon con-
text optimization (CCO) method optimizes sequences
with regard to codon context only; and the multi-
objective codon optimization (MOCO) method simul-
taneously considers both ICU and CC. Thus, the
resultant sequence is ICU-/CC-optimal when its ICU/CC
distribution is closest to the organism’s reference ICU/
CC distribution calculated based on the sequences of na-
tive high-expression genes. Based on the mathematical
formulation presented in Methods, the ICO problem can
be described as the maximization of ICU fitness, ΨICU
(see Eqn. 23), subject to the constraint that the codon se-
quence can be translated into the target protein (see
Eqns. 3, 4 and 11). Due to the discrete codon variables
and nonlinear fitness expression of ΨICU, ICO is classi-
fied a mixed-integer nonlinear programming (MINLP)
problem. Nonetheless, it can be linearized using a strat-
egy shown in an earlier study by decomposing the non-
linear |p0
k − p1
k| term (see Equation 23) into a series of
linear and integer constraints which consist of binary
and positive real variables [24]. The resultant mixed-
integer linear programming (MILP) problem can be
solved using well established computational methods
such as either branch-and-bound and branch-and-cut
[25]. However, due to the large and discrete search space
which contains all possible DNA sequences that can en-
code the target protein, solving the MILP using these
methods may require a long computational time. Thus,
alternative methods, such as GASCO [26] and QPSOBT
[27], have been proposed for solving ICO using genetic
algorithm and particle swarm optimization. Although
these heuristic methods are more efficient than conven-
tional MILP solving procedures, they still require a sig-
nificant amount of computational resources due to the
iterative nature of the algorithms. To circumvent the
high computational costs, we developed the non-iterative
method for solving ICO using the following steps:
I1. Calculate the host’s individual codon usage
distribution, p0
k.
I2. Calculate the subject’s amino acid counts, θAA,1
j .
I3. Calculate the optimal codon counts for the subject
using the expression: θkC;opt ¼ pk0 
X21
j¼1
θjA;1  1 αj ¼
h
f κk
 g ∀k∈ 1; 2; . . . ; 64f g.
I4. For each τi in the subject’s sequence, randomly
assign a codon κ k if θC
k > 0, and decrement θC,opt
k by
one.
I5. Repeat step I4 for all amino acids of the target
protein from τ1,1 to τn,1.
Similarly, CCO can be formulated as the maximization
of CC fitness, ΨCC (see Eqn. 26), subject to the constraint
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target protein (see Eqns. 7, 8 and 12). To find the solution
for CCO, the procedure in ICO may not be applicable due
to the computational complexity which arises from the de-
pendency of adjacent codon pairs. For example, given a
codon pair “AUG-AGA” in a 5’-3’ direction, the following
codon pair must only start with “AGA”. Therefore, if we
had adopted the ICO procedure to directly identify the
codon pairs and randomly assign them to the respective
amino acid pairs, there could be conflicting codon pair
assignments in certain parts of the sequence. Since the
characteristic of independency, which was exploited to de-
velop a simple solution procedure for ICO, is absent in
the CCO problem, we resort to a more sophisticated com-
putational approach.
The CCO problem can be conceptualized in a similar
way as the well-known traveling salesman problem
whereby the traversing from one codon to the next adja-
cent codon is analogous to the salesman traveling from
one city to the next [28]. Since there will be a “cost” in-
curred by taking a particular “codon path”, the CCO prob-
lem aims to minimize of the total cost for traveling a
codon path that is able to code the desired protein se-
quence. However, the CCO problem is more complex
than the traveling salesman problem due to the nonlinear
cost function evaluated based on the frequency of codon
pair occurrence (see Materials and Methods). For an aver-
age sized protein consisting 300 amino acids, the total
number of codon paths can be as many as 10100. Finding
an optimal solution for such a large-scale combinatorial
problem within an acceptable period of computation time
can only be achieved via heuristic optimization methods.
Incidentally, the use of genetic algorithm [29] provides an
intuitive framework whereby codon path candidates are
“evolved” towards optimal CC through techniques mim-
icking natural evolutionary processes such as selection,
crossover or recombination and mutation. Thus, the pro-
cedure for solving CCO is as follows:
C1. Randomly initialize a population of coding
sequences for target protein.
C2. Evaluate the CC fitness of each sequence in the
population.
C3. Rank the sequences by CC fitness and check
termination criterion.
C4. If termination criterion is not satisfied, select
the “fittest” sequences (top 50% of the
population) as the parents for creation
of offsprings via recombination
and mutation.
C5. Combine the parents and offsprings to form a new
population.
C6. Repeat steps C2 to C5 until termination criterion is
satisfied.In step C3, the termination criterion depends on the de-
gree of improvement in best CC fitness values for con-
secutive generations of the genetic algorithm. If the
improvement in CC fitness across many generations is not
significant, the algorithm is said to have converged. In this
study, the CC optimization algorithm is set to terminate
when there is less than 0.5% increase in CC fitness across
100 generations, i.e. ΨCC
(r + 100)/ΨCC
(r) < 0.005 where r refers to
the rth generation of the genetic algorithm. When the ter-
mination criterion is not satisfied, the subsequent step C4
will perform an elitist selection such that the fittest 50% of
the population are always selected for reproduction of off-
springs through recombination and mutation. During re-
combination, a pair of parents is chosen at random and a
crossover is carried out at a randomly selected position in
the parents’ sequences to create 2 new individuals as off-
springs. The offsprings subsequently undergo a random
point mutation before they are combined with the parents
to form the new generation.
Unlike traditional implementations of genetic algorithm
where individuals in the population are represented as as
0–1 bit strings, the presented CC optimization algorithm
represents each individual as a sequential list of character
triplets indicating the respective codons. Therefore, the
codons can be manipulated directly with reference to a
hash table which defines the synonymous codons for each
amino acid. As a result, the protein encoded by the coding
sequences is always the same in the genetic algorithm
since crossovers only occur at the boundary of the codon
triplets and mutation is always performed with reference
to the hash table of synonymous codons for each respect-
ive amino acid.
Based on the formulations for ICU and CC optimization,
the MOCO problem, which is an integration of both, can
be described as maximizing both ICU and CC fitness, i.e.
max (ΨICU,ΨCC), subject to the constraints that both the
codon and codon pair sequences can be translated into the
target protein sequence. As such, due to the complexity
attributed to CC optimization, solution to MOCO will also
require a heuristic method. In this case, the nondominated
sorting genetic algorithm-II (NSGA-II) is used to solve the
multi-objective optimization problem [30]. The procedure
for NSGA-II is similar to that presented for CC
optimization except for additional steps required to identify
the nondominated solution sets and the ranking of these
sets to identify the pareto optimum front. The NSGA-II
procedure for solving the MOCO problem is as follows:
M1. Randomly initialize a population of coding
sequences for target protein.
M2. Evaluate ICU and CC fitness of each sequence in
the population.
M3. Group the sequences into nondominated sets and
rank the sets.
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M5. If termination criterion is not satisfied, select the
“fittest” sequences (top 50% of the population) as
the parents for creation of offsprings via
recombination and mutation.
M6. Combine the parents and offsprings to form a new
population.
M7. Repeat steps M2 to M5 until termination criterion
is satisfied.
The identification and ranking of nondominated sets
in step M3 is performed via pair-wise comparison of the
sequences’ ICU and CC fitness. For a given pair of





2 ), the domination status can be evaluated
using the following rules:
 If (ΨICU1 >ΨICU2 ) and (ΨCC1 ≥ΨCC2 ), sequence 1
dominates sequence 2.Figure 1 Multi-objective codon optimization solution. The optimal solu If (ΨICU1 ≥ΨICU2 ) and (ΨCC1 >ΨCC2 ), sequence 1
dominates sequence 2.
 If (ΨICU1 <ΨICU2 ) and (ΨCC1 ≤ΨCC2 ), sequence 2
dominates sequence 1.
 If (ΨICU1 ≤ΨICU2 ) and (ΨCC1 <ΨCC2 ), sequence 2
dominates sequence 1.
Whenever a particular sequence is found to be domi-
nated by another sequence, the domination rank of the
former sequence is lowered. As such, the grouping and
sorting of the nondominated sets are performed simultan-
eously in step M3 (Figure 1). In the original nondominated
sorting algorithm [30], the set of individuals that is domi-
nated by every individual is stored in memory. Therefore,
for a total population of n, the total storage requirement is
O(n2). However, for the abovementioned algorithm, only
O(n) storage is required for storing the domination value
of each individual. In terms of computational complexity,
both the original and modified algorithm requires at mosttions generated by MOCO lies on the pareto front (region in yellow).
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n individuals have to be compared pair-wise for every ob-
jective to be optimized. Therefore, the nondominated sort-
ing algorithm presented in this thesis is superior on the
whole, especially with regards to computational storage re-
quirement which can become an important issue when
dealing with long coding sequences.
The output of multi-objective optimization is a set of
solutions also known as the pareto optimal front. Since
the aim of MOCO is to examine the relative effects of
ICU and CC optimization, it is not necessary to analyze
all the sequences in the pareto optimal front. Instead, the
solution which is nearest to the ideal point will represent
the sequence with balanced ICU and CC optimality. As
such, the solutions of ICO, CCO and MOCO will subse-
quently be referred to as xICO, xCCO and xMOCO respectively
(Figure 1). The program for performing ICO, CCO and
MOCO can be downloaded from the following link: http://
bioinfo.bti.a-star.edu.sg/tool/CodonOptimization/.
Finding the codon preference
The entire workflow for codon optimization of a target
protein sequence begins with the identification of the
host’s preferred ICU and CC distributions as the refer-
ence (Figure 2). These ICU and CC distributions should
ideally capture codon usage patterns that correspond to
efficient translation of mRNA to protein. Therefore, the
first step of codon optimization identifies the reference
ICU and CC distributions by characterizing the under-
lying mechanisms of efficient translation which can be
achieved through transcriptome, translatome and prote-
ome profiling as demonstrated in earlier studies [31,32].
However, such large-scale experimental data are not
readily available for the extraction of codon usage prefer-
ence information in all the expression hosts considered
in this study. Alternatively, it is assumed that the organ-
isms have evolved to conserve resources by producing
high amounts of transcripts for genes that will also be
efficiently translated. As such, the widely available tran-
scriptome data from microarray experiments can be
used to identify the highly expressed and efficiently
translated genes. Thus, the codon pattern of the host’s
native high-expression genes will be a suitable reference
point for codon optimization.
The step for selecting high-expression genes codon pat-
tern for codon optimization is only relevant if the follow-
ing two conditions are true: (1) ICU and CC distributions
of high-expression genes are significantly biased and non-
random; and (2) there is a significant difference in ICU
and CC distribution between highly expressed genes and
all the genes in the host organism’s genome. It is noted
that if the first condition is false, there is no codon (pair)
bias and codons can be assigned randomly based on a
uniform distribution; if the second condition is false, thecomputation of ICU and CC distributions based on all
the genes in the genome will be sufficient to characterize
the ICU and CC preference of the organism without the
need for selecting high-expression genes.
To determine the significance of ICU and CC biases,
we applied the Pearson’s chi-squared test (see Materials
and Methods). Using a p-value cut-off of 0.05, the ICU
and CC distributions of at least 80% of the amino acids
(pairs) amenable to the chi-squared test were found to
be significantly biased in the micro-organisms (Table 1).
In the high-expression genes, aspartate was found to be
the only one among all amino acids exhibiting an ICU
distribution that is not significantly different from the
unbiased distribution for E. coli, P. pastoris and S. cerevi-
siae. Similarly, more than 80% of the amino acids (pairs)
show significant difference in ICU and CC distributions
between high-expression genes and all genes in the gen-
omes of these three microbes. Contrastingly, 80% amino
acids did not show significant difference in CC distribu-
tions between high-expression genes and all genes in L.
lactis, suggesting that the selection of highly expressed
genes may not be required to establish the CC prefer-
ence of L. lactis. By applying the principal component
analysis, we can observe that the ICU and CC distribu-
tions for all types of genes in L. lactis are close to one
another when compared to genes from other organisms
(Figure 3). This indicates that the short listing of highly
expressed genes may not be necessary for organisms like
L. lactis. Nonetheless, we recommend the identification
of high-expression genes to characterize the ICU and
CC preference of any host, such that there is a better
level of confidence that the optimized recombinant gene
can be efficiently expressed.
Performance of codon optimization methods
The performance of each optimization approach was eval-
uated using a leave-one-out cross-validation, where a gene
is randomly selected from the entire set of high-
expression genes for sequence optimization while the rest
of the genes will be used as the training set to calculate
the reference ICU and CC distribution (Figure 4). The
predicted optimum sequences are compared with the ori-
ginal native sequences to evaluate the performance of each
codon optimization approach (see Additional file 1 for the
sequences of the wild-type and optimized genes). As the
degree of similarity to the wild-type high expression genes
indicates the gene expressivity potential of the optimized
sequences, the quality of each optimized sequence was
measured in terms of the percentage of codons matching
the corresponding native sequence, denoted by PM. From
the results, the xICO, xCCO and xMOCO solutions were gen-
erally found to be more similar to the native genes than
the random sequences generated by RCA indicating that
all the optimization approaches are indeed capable of
Figure 2 General codon optimization workflow. In the step of codon optimization, either ICO, CCO or MOCO can be used to optimized the
sequence.
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trol (Figure 4). The PM values of xICO, xCCO, xMOCO and
xRCA sequences for each gene are further compared in a
“tournament” style to show the relative performance of
each optimization method. In the tournament matrix(Table 2), each cell shows the number of wins by the
method in the left-most column against that in the upper-
most row. Whenever the numbers of wins and losses (i.e.
cells diagonally opposite of each other) do not sum up to
100, the shortfall will be equal to the number of draws.
Table 1 ICU and CC biasness analysis
E. coli L. lactis P. pastoris S. cerevisiae
Null hypothesis (H0) D
H = U DH = DA DH = U DH = DA DH = U DH = DA DH = U DH = DA
Alternative hypothesis (H1) D
H ≠ U DH ≠ DA DH ≠ U DH ≠ DA DH ≠ U DH ≠ DA DH ≠ U DH ≠ DA
No. of biased amino acids (P-value < 0.05) 18 17 19 17 18 19 18 19
No. of unbiased amino acids (P-value ≥ 0.05) 1 2 0 2 1 0 1 0
No. of singular amino acids 2 2 2 2 2 2 2 2
No. of unevaluated amino acids (Expect count < 5) 0 0 0 0 0 0 0 0
Total no. of amino acids 21 21 21 21 21 21 21 21
No. of biased amino acid pairs (P-value < 0.05) 314 99 327 15 354 259 372 282
No. of unbiased amino acid pairs (P-value ≥ 0.05) 26 23 12 65 38 36 19 9
No. of singular amino acid pairs 4 4 4 4 4 4 4 4
No. of unevaluated amino acid pairs (Expect count < 5) 76 294 77 336 24 121 25 125
Total no. of amino acid pairs 420 420 420 420 420 420 420 420
The chi-squared statistic is computed based on the observed occurrence of each codon (pair) and the expected occurrence under the null hypothesis of uniform
distribution. Any amino acid (pair) with p-value < 0.05 is considered to exhibit significantly biased codon (pair) usage. Singular amino acids (methionine and
tryptophan) and singular amino acid pairs (pairs only consisting of methionine and/or tryptophan) are not amenable to the biasness analysis since they are not
encoded by more than one synonymous codon (pair). Chi-squared statistic and p-value are not calculated for amino acid (pair) with expected counts less than 5
(see Materials and Methods for details). Abbreviations: DA, codon (pair) distribution of all genes in the genome; DH, codon (pair) distribution of high-expression
genes; U, uniform distribution.
Chung and Lee BMC Systems Biology 2012, 6:134 Page 7 of 14
http://www.biomedcentral.com/1752-0509/6/134Through the comparison of ICO and CCO, the xCCO
solutions have a higher average percentage of codon
matches than xICO sequences for all four microbes
(Figure 4), with at least 90% of the xCCO sequences
matching the native corresponding sequences better
than those generated by ICO (Table 2). This result indi-
cates that CC fitness can be a more important design
parameter for sequence optimization than ICU fitness
which has been a conventional design criterion imple-
mented in several software tools. While it appears likely
that the integration of CCO with ICO under a multi-
objective optimization framework can potentially lead
to even better sequence design, results from our MOCO
analysis suggest otherwise. The average of PM value of
xMOCO were observed to be lower than that of xCCO,
indicating that the consideration of ICU fitness inFigure 3 PCA of ICU and CC distributions. The first and second principa
the ICU and CC distributions of (top 5%) high-expression genes (H), (bottom
genomes of E. coli (EC), L. lactis (LL), P. pastoris (PP) and S. cerevisiae (SC). Thaddition to CC fitness can be detrimental to the se-
quence design. To our best knowledge, no such formal
evaluation of the relative impact of ICU and CC fitness
on synthetic gene design has been presented to date.
Hence, based on the promising in silico validation
results which implicate CC as an important design par-
ameter for optimizing sequences, the newly developed
CCO procedure can potentially supersede the ICU
optimization techniques currently implemented in gene
design software tools. It is noted that similar observa-
tions on the relative performance of ICO, CCO and
MOCO were made when we performed the in silico
leave-one-out cross-validation on the set of 27 high-
expression genes of E. coli reported in an earlier study
[33]. Details of this analysis can be found in Additional
file 2.l components (PC1 and PC2) are plotted to show the differences in
5%) low-expression genes (L) and all genes (A) found in the
e unbiased distribution (U) is also included for each plot as reference.
Figure 4 Codon optimization validation. The in silico cross-validation of the optimization procedures is performed according to the presented
workflow.
Chung and Lee BMC Systems Biology 2012, 6:134 Page 8 of 14
http://www.biomedcentral.com/1752-0509/6/134Discussion
Capturing the preferred codon usage patterns
Earlier codon optimization studies have recommended the
usage of high expression genes to design the recombinantgene for efficient heterologous expression [12,13,34]. In
the analysis of codon usage patterns, the significant dis-
tinction in the ICU and CC distributions between highly
expressed and other genes corroborated the relevance of
Table 2 Tournament matrix
xICO xCCO xMOCO xRCA
7 19 95
2 18 99












xRCA 6 0 1
1 0 0
For every gene, the pM of the optimal sequences generated by respective
optimization approaches are compared pair-wise for each expression host. The
numbers of tournament wins/losses by each approach for all the genes in
each expression host are added up. The sequences generated by ICO, CCO,
MOCO and RCA are indicated as xICO, xCCO, xMOCO and xRCA respectively. In
each cell, the numbers from top-most to bottom-most corresponds to the
data for E. coli, L. lactis, P. pastoris and S. cerevisiae, respectively.
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ferred codon usage patterns. It is noted that although
there is codon usage information readily available in the
Codon Usage Database (http://www.kazusa.or.jp/codon/)
[35], these data may not be useful as prior filtering of
highly expressed genes was not performed. Such codon
usage data may reflect some degree of preference for
“rare” codons, thus leading to low gene expression [36].
Several options are available for quantifying the codon
usage patterns. In this study, we have adopted the method
of treating the ICU and CC distributions as a vector of fre-
quency values to capture the relative abundance of indi-
vidual codons and codon pairs. An earlier well-known
method for quantifying codon usage bias is the codon
adaptation index (CAI). The CAI has been widely used for
codon optimization due to its observed correlation with
gene expressivity [34]. However, by designing a gene
through the maximization of CAI, the resultant coding se-
quence will become a “one amino acid – one codon” de-
sign where CAI = 1.0. This sequence design may not be
desirable as the overexpression of this gene can lead to
very rapid depletion of the specific cognate tRNAs result-
ing in tRNA pool imbalance, which can in turn cause an
increase in translational errors [37]. In this aspect, the
ICU fitness measure will be a better performance criterion
than CAI since the former allows a small number of rare
codons to be included in the final sequence. Furthermore,the calculation of CAI, as described in its original paper
[34], is intrinsically based on individual codon usage and
does not have the capability to account for codon pairing.
Therefore, the information captured by the CC fitness
cannot be reflected in the CAI value.
Therefore, the proposed approach of optimizing codons
according to the complete ICU and CC distributions of
highly expressed genes will be suitable to alleviate the
problem of tRNA pool imbalance when the cell is induced
to overexpress the target gene. As such, the concept of
CAI was not considered in this study as this single value
does not capture the details in ICU and CC distributions.
Other potential issues in efficacy of CCO
Codon usage has been shown to affect the accuracy and
speed of translation [38,39]. Hence, the concept of CCO
implementation is to identify favorable codon pairings
that can lead to more efficient protein synthesis process.
Notably, an optimization framework based on the dy-
namic modeling of protein translation has been recently
developed to identify suitable codon placements to im-
prove translation elongation speed [40]. Although this
method provides a mechanistic understanding of how
codon choice affects translation efficiency, it requires a
protein translation kinetic model and codon-specific
elongation rates which may not be readily available for
organisms other than E. coli as shown in previous stud-
ies [32,41]. Therefore, CCO may be a better alternative
as it can achieve the aim of enhancing translation effi-
ciency while having the advantage of utilizing informa-
tion, including genome sequence and gene expression
data, which are easily accessible in public databases such
as the Gene Expression Omnibus (www.ncbi.nlm.nih.
gov/geo/) and GenBank (www.ncbi.nlm.nih.gov/gen-
bank/). Incidentally, there was evidence suggesting that
translation initiation rather than elongation is the rate lim-
iting step [42]. Nonetheless, CCO generated sequences
can indirectly increase translation initiation by freeing up
more ribosomes through enhanced translation elongation
rates. The increased pool of free ribosomes can then help
to improve translation initiation by mass action effect.
On the other hand, translation initiation can also be
affected by the mRNA structure of the initiation site. At the
primary structure level, Shine-Dalgarno sequence and
Kozak sequence should be added to the 5’ end of the cod-
ing sequence since previous studies have shown that they
are required for recognition of the AUG start codon to ini-
tiate translation in prokaryotes and eukaryotes, respectively,
[43]. At the secondary structure level, it was found that
hairpin, stem-loop and pseudoknot mRNA structures can
repress protein translation [44]. Although this suggests that
the computationally intensive mRNA secondary structure
evaluation may be required for designing synthetic genes, it
was also reported that the helicase activity of ribosome is
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tion [45]. Therefore, we suggest using the mRNA secondary
structure analysis only as a supplementary step for the CC-
optimized sequences such that no significant computational
cost is added to the main CCO procedure.
CCO tool for synthetic biology
To further develop CCO into a software tool for design-
ing synthetic genes, several other factors may have to be
considered. From the experimental aspect, the gene
optimization should take into consideration the types of
restriction enzymes used for vector construction such that
the restriction sites DNA motifs are avoided to prevent
unnecessary cleavage of the coding sequence. In certain
cases where the optimized coding sequence tends to have
nucleotide repeats, additional steps may be required to
avoid the repeats or inverted repeats which may lead to
DNA recombination or formation of mRNA hairpin loops,
respectively, that will reduce the heterologous expressivity
of the target protein [46,47]. In addition, sequence hom-
ology may also be considered to design genes that are re-
sistant to RNA interference such that complementary
sequences of the silencing RNAs are avoided in the coding
sequence [48]. Possible strategies to tackle the aforemen-
tioned issues during gene optimization have been dis-
cussed in a previous study [20].
The optimal sequences generated by CCO are not found
in any natural organism. Thus, the CCO software tool
should also consider challenges involved in the synthesis
of these artificial genes. The current technology for de
novo gene synthesis involves the chemical synthesis of
short oligonucleotides followed by ligation- or PCR-
mediated assembly of the oligonucleotides to form the
complete gene [49]. The way in which a long coding se-
quence is broken down into short oligonucleotides has to
be properly designed to minimize the oligonucleotide syn-
thesis error rate and maximize the uniformity of the oligo-
nucleotides’ annealing temperatures for efficient assembly.
Several methods such as DNAWorks [50], Gene2Oligo
[51] and TmPrime [52] have been proposed to these goals
in oligonucleotide design optimization for gene synthesis.
Although these oligonucleotide optimization methods can
be performed independently from the codon optimization
procedure, these two processes can be integrated to fa-
cilitate the “design-to-synthesis” workflow. As long as
the current gene synthesis paradigm prevails, research-
ers can further explore the possibility of developing an
integrated codon and oligonucleotide optimization soft-
ware tool to effectively and systematically design high
performance synthetic genes for protein expression.
Potential applications of CCO
The motivation behind codon optimization is usually to
enhance the expression of foreign genes in expressionhosts such as E. coli, P. pastoris and S.cerevisiae. In
addition, codon optimization can also be used to gener-
ate synthetic designs of native genes for metabolic engin-
eering applications. While conventional overexpression
of native metabolic genes is achieved by increasing gene
copy number through the introduction of plasmids,
codon optimization provides an alternative approach for
enhancing pathway utilization via insertion of high-
expression synthetic genes of the respective metabolic
enzymes into the host’s genome. The latter technique
can be advantageous as it obviates the metabolic burden
associated with plasmid maintenance [53-55], thus allow-
ing the cells to have more resources for growth and bio-
chemical production.
Apart from biotechnological applications, codon
optimization can also be used in biomedical research
where modulation of protein expression is required to
alter physiological response. For example, in the devel-
opment of vaccines against viruses, one approach is to
genetically manipulate the virus to obtain a “live attenu-
ated” strain as the vaccine. Such a vaccine, when admi-
nistered to the host, will elicit an immune response for
the host to develop immunologic memory and specific
immunity against the virus without severe disruption to
the overall physiology. Some conventional methods of
developing live attenuated vaccines include laboratory
adaptation of virus in non-human hosts and random/site-
directed mutagenesis [56]. Since the wild-type virus is able
to hijack the gene expression machinery of the host for
replication, the de-optimization of viral codon usage
can lead to the development of live attenuated vaccines
as demonstrated in a recent study [19]. Therefore, the
CCO framework developed in this study can be slightly
modified to design synthetic virus consisting of more
rare codons that can be used as vaccines. Specifically,
we can either invert the objective function to minimize
CC fitness or alter the target CC distribution during
the execution of the optimization procedure to design
the sequence of the attenuated virus.
Conclusions
Through novel implementations of ICO, CCO and
MOCO, the high-expression genes of four microbial
hosts were optimized and cross-validated to compare
the performance of the optimized sequences. Amongst
all the optimization approaches, CCO was found to
generate the sequences that are most similar to the na-
tive high-expression genes, indicating a greater potential
for high in vivo protein expression. Contrary to the con-
ventional practice which adopts ICU optimization as
the key element of gene design, our study suggests that
CC fitness is a more relevant design parameter for opti-
mizing the sequence for improved heterologous protein
expression. Thus, future works to incorporate the
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software can lead to the development of more efficient
platforms for gene optimization.
Methods
Identifying highly expressed genes
Provided that highly expressed genes have evolved to
adopt optimal codon patterns, information on ICU and
CC preference of any organism can be extracted from
the DNA sequences of the high-expression genes. In this
sense, we used published microarray data of E. coli [57],
L. lactis [58], P. pastoris [59] and S. cerevisiae [60] from
various experimental conditions to identify the top 5% of
genes with the highest expression value for each mi-
crobe. The ICU and CC of these genes were then
extracted from their corresponding DNA coding
sequences that can be obtained from publicly available
genome annotations for E. coli [61], L. lactis [62], P. pas-
toris [63] and S. cerevisiae [64]. Each host’s ICU and CC
preference can be represented as the frequency of occur-
rence of individual codons and codon pairs found in the
sequences of the highly expressed genes. These ICU and
CC distributions are then be used as the targets for
the respective codon optimization methods. For the
evaluation of ICU and CC biasness difference between
high- and low-expression genes, the low-expression
genes are identified in a similar way whereby the bottom
5% of the genes with the lowest expression values are
consolidated (see Additional file 1 for a list of high-
expression genes).ICU and CC biasness
To compute the significance of codon (pair) usage bias,
we resort to the Pearson’s chi-squared test. Based on
the null hypothesis that “the ICU (CC) of high-
expression genes follows the uniform/unbiased distribu-











H are the expected and observed num-
bers of synonymous codon (pair) i encoding amino acid
(pair) j, respectively. The constant nj
H refers to the number
of unique synonymous codon (pair) encoding the amino
acid j; for example, the n j
H values for asparagine, glycine
and leucine are 2, 4, and 6 respectively. The superscript
“H” indicates that only the high-expression genes are used
to evaluate the respective values. Given the null hypothesis
of unbiased codon (pair) usage, Eij





H refers to the total number of aminoacid (pair) j found in the high-expression genes. The p-
value is then evaluated by comparing the calculated Χj
2
against the χ 2 distribution with (nj
H − 1) degrees of free-




OHij ¼ NHj . Using a p-value cut-off
of 0.05, we can identify the amino acid (pair) with biased
ICU (CC) distribution that is significantly different from
the normal distribution. This test of ICU and CC bias-
ness will be referred to as “χ 2 Test 1”. To ensure that
the statistical adequacy of this chi-squared test, any
amino acid (pair) with low expected occurrence (i.e.
Eij
H < 5) will be omitted from this analysis as recom-
mended in an earlier study [65]. Furthermore, chi-
squared test of singular amino acids (methionine and
tryptophan) and amino acid pairs (pairs only consisting
of methionine and/or tryptophan) are also not relevant
since they are not encoded by more than one syn-
onymous codon (pair) such that the chi-squared statis-
tic will always be equal to 1.
The presented Pearson’s chi-squared formulation is
slightly modified to determine whether the ICU (CC)
is significantly different between high-expression genes
and all genes in the genome. Based on the null hy-
pothesis as “ICU (CC) of high-expression genes is the
same as that of all genes in the genome”, the
expected number of codon (pair) i in high-expression








A refers the observed number of codon (pair)
i encoding amino acid (pair) j and Nj
A refers to the
total number of amino acid (pair) j. The superscript
“A” indicates that all genes in the host’s genome are
used for evaluating the respective values. By substitut-
ing Eij
H with ~EHij in the expression for Χj
2, the chi-
squared statistic to test the difference in ICU (CC)
distribution between high-expression genes and all
genes in the host’s genome can be calculated.
ICU and CC fitness evaluation
In this study, the target gene, subsequently known as the
“subject”, is optimized such that the final synthetic se-
quence design will exhibit ICU and/or CC distributions
that are as similar as possible to those preferred by the
host’s organism. The ICU and CC fitness values can be
used to quantify the degree of similarity in ICU and CC
distributions between the subject and the host. Before
formulating the ICU and CC fitness, we present the
mathematical expression of the coding sequence and
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¼ AAA;AAC;AAG; . . . ;UUG;UUUf g ∀i
ð6Þ
where τi,1 refers to the amino acid occupying the i
th pos-
ition of the amino acid sequence SA,1 with the subscript
1 indicating the target protein; τi,1 also belongs to the
set A of 21 unique amino acids αj. Similarly, λi,1, a codon
from the set K of 64 unique codons κk, represents the
codon variable in the ith position of the target coding se-
quence SC,1. It is noted that the coding sequence is ex-
press as a sequence of codons instead of nucleotides
since codon usage patterns is the key concern. As codon
context is another key issue to be examined, we also in-
clude the following mathematical expressions for amino
acid pairs and codon pairs:




SCC;1 ¼ AUGAGA;AGAUUU ;UUUCCU ; . . . ;f




ωi;1∈Β ¼ AA;AC;CA; . . . ;W;Yf g
¼ βj 420j¼1 ∀i∈ 1; . . . ; n 1f g ð9Þ
γi;1∈Ρ ¼ AAAAAA; . . . ;UUUUUUf g
¼ ρk 3904k¼1 ∀i∈ 1; . . . ; n 1f g ð10Þ
By defining a function to f translate codon(s) to the
corresponding amino acid(s) and a concatenation func-
tion g(a,b) to append the string b to right of string a, we
have the following mathematical relationships for τi,1,
ωi,1, λi,1 and γi,1:
f λi;1




g τi;1; τ iþ1ð Þ;1
  ¼ ωi;1 ð13Þ
g λi;1; λ iþ1ð Þ;1
  ¼ γ i;1 ð14ÞThe ICU distribution can be defined as the frequency
of each unique codon based on its total number of
occurrences in the sequence(s). Based on the mathemat-
ical formulation presented hitherto, the required math-
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1 λi;1 ¼ κ k
 
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θjA;0  1 αj ¼ f κk





θjA;1  1 αj ¼ f κk





1 λi;0 ¼ κk
 




1 λi;0 ¼ κk
 
∀k∈ 1; 2; . . . ; 64f g ð22Þ
where 1{•} is an indicator function such that




The count variables θAA
j and θC
k refer to the numbers
of occurrences of amino acid j and codon k, respectively,
found in the host’s (indicated by subscript “0”) or sub-
ject’s (indicated by subscript “1”) sequence(s), while pk
represents the frequency of occurrence of codon k. Ac-
cordingly, the ICU fitness can be expressed as:







The ICU fitness, ΨICU, was divided by 64 such that the
numerical value will reflect the average fitness of all
codons. In a similar way, if we denote the frequency of
occurrence of codon pair k as qk, the CC fitness can be
calculated as:




θjAA;0  1 βj ¼ f ρk





θjAA;1  1 βj ¼ f ρk









(See Additional file 3 for further details of the math-
ematical formulation).
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